Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
US stem-cell therapy firm NeoStem predicts that output of its China-based generic antibiotics subsidiary Suzhou Erye Pharmaceutical will increase after further manufacturing approval from the SFDA.
Sartorius Stedim Biotech (SSB) has teamed up with packaging firm Sudpack Medica AG in a deal focused on making plastic films for biopharmaceutical industry applications.
Switzerland-based life sciences supplier Lonza says it will invest CHF10m (€8m) to expand a Singapore plant that is part of its custom biomanufacturing business.
Irish pharma giant Elan is investing $20m (€14m) in US drug developer Proteostasis Therapeutics to speed the research and development of disease modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders.
By Lee S. Scheible, RPh., CA-AM and Jeffrey S Kasher, PhD
Sponsors need to abandon the ‘single trial, random, tactical sourcing approach’ in favour of a model flexible enough for a variety of study designs and research needs according to Eli Lilly experts Lee Scheible and Jeffrey S Kasher in this exclusive guest...
PolyPid claims its new polymer-lipid combination delivery tech will let pharmas set precise release characteristics for a variety of small molecule, protein and nucleic acid-base drugs.
Florida-based contract manufacturing organisation (CMO), Goodwin Biotechnology (GBI), has entered into an agreement with protein and monoclonal antibody drug developer, Rafagen, to provide cell line engineering and biological contract manufacturing services.
UK-based drugmaker Shire has unveiled plans to buy Advanced BioHealing (ABH) citing the lack of generic competition in the regenerative medicines sector as a factor.
Californian biotech tool manufacturer Life Technologies has teamed with German contract research organisation (CRO) ProBiogen to release a range of royalty-free Gibco Freedom Cell Line Development Kits.
Californian Bioreactor manufacturer, PBS Biotech, has launched its new PBS 3 single-use bioreactor system for the development of biological therapeutics, vaccines and biosimilars.
EMD Millipore has opened a training facility in China as an education resource for the country’s rapidly expanding biopharmaceutical manufacturing and development sector.
Sartorius Stedim Biotech (SSB) has launched a new small-scale bioreactor citing growing biopharmaceutical company demand for scale-up technologies as the key driver for its development.
Pharma giant Eli Lilly and medical device maker Medtronic are to collaborate on the research and development of an implantable drug delivery system for the treatment of Parkinson’s disease.
US-based vaccine specialist, Caliber Biotherapeutics, has opened the world’s largest modular, plant-made pharmaceutical manufacturing facility at its headquarters in Bryan, Texas.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Novella and Publicis.
West Pharmaceutical Services is preparing to increase its manufacturing capacity in response to an increased demand for its Daikyo Crystal Zenith 1mL syringe system.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at A10, Crystal Pharmatech and Algos.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new role for former Genzyme CEO and a leadership change at Astellas Europe.
How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.
The biomanufacturing industry needs to adopt an integrated approach to upstream and downstream processing to boost efficiency and productivity according to EMD Millipore.
Chiltern International, a global contract research organisation (CRO) has expanded its European operations with the opening of a new office in the Netherlands.
Almac Pharma Services has expanded its cold storage capacity for biopharmaceuticals, continuing the contract manufacturing organisation’s (CMO) busy expansion programme.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PharmStar, Cephalon, Covidien and Catalent.